SKI Market

A+| A| A-|

Indian Indices

Sensex

76,264.33 736.38
( 0.97%)

Global Indices

Nasdaq

51,233.54 363.79
(0.72%)

Dow Jones

7,453.14 37.84
(0.51%)

Hang Seng

69,318.21 3,298.17
(5.00%)

Nikkei 225

10,460.24 156.36
(1.52%)

Forex

USD-INR

95.49 0.16
(0.17%)

EUR-INR

110.25 0.17
(0.15%)

GBP-INR

127.74 0.15
(0.12%)

JPY-INR

0.60 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

ERIS Lifesciences Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

540596

INE406M01024

230.6075957

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ERIS

76.54

19439.6

EPS(TTM)

Face Value()

Div & Yield %

18.33

0.51

Back

agarwal industrial corporation ltd

Hariyana Ventures reports standalone net loss of Rs 0.01 crore in the December 2025 quarter

Feb 06,2026

Net loss of Hariyana Ventures reported to Rs 0.01 crore in the quarter ended December 2025 as against net profit of Rs 0.48 crore during the previous quarter ended December 2024. There were no Sales reported in the quarter ended December 2025 as against Rs 0.51 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	0	0.51	-100
OPM %	0	94.12	-
PBDT	0	0.50	-100
PBT	-0.01	0.49	PL
NP	-0.01	0.48	PL

76,264.33 736.38 ( 0.97%)

51,233.54 363.79 (0.72%)

7,453.14 37.84 (0.51%)

69,318.21 3,298.17 (5.00%)

10,460.24 156.36 (1.52%)

95.49 0.16 (0.17%)

110.25 0.17 (0.15%)

127.74 0.15 (0.12%)

0.60 0.00 (0.21%)